drugset / Trial / NCT03349528

Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression

NCT03349528 ↗

Phase 2 Active not recruiting 80 enrolled Sheppard Pratt Health System
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if taking a probiotic supplement versus a placebo will reduce relapse and improve the clinical course among participants who have been hospitalized for bipolar depression.

Timeline

Start
2018-12-11
Primary completion
2026-12
Completion
2027-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Probiotic Supplement Other / unclassified — Oral

Indications